Abstract:p53 promotes tumor suppression through its ability to function as a transcriptional factor and is activated by posttranslational modifications that include acetylation. Our earlier study demonstrated that p53 acetylation can enhance its sequence-specific DNA binding in vitro, and this notion was later confirmed in several other studies. However, a recent study has reported that in vitro acetylation of p53 fails to stimulate its DNA binding to large DNA fragments, raising an important issue that requires further investigation. Here, we show that unacetylated p53 is able to bind weakly to its consensus site within the context of large DNA fragments, although it completely fails to bind the same site within short oligonucleotide probes. Strikingly, by using highly purified and fully acetylated p53 proteins obtained from cells, we show that acetylation of the C-terminal domain can dramatically enhance site-specific DNA binding on both short oligonucleotide probes and long DNA fragments. Moreover, endogenous p53 apparently can be fully acetylated in response to DNA damage when both histone deacetylase complex 1 (HDAC1)- and Sir2-mediated deacetylation are inhibited, indicating dynamic p53 acetylation and deacetylation events during the DNA damage response. Finally, we also show that acetylation of endogenous p53 indeed significantly augments its ability to bind an endogenous target gene and that p53 acetylation levels correlate well with p53-mediated transcriptional activation in vivo. Thus, our results clarify some of the confusion surrounding acetylation-mediated effects on p53 binding to DNA and suggest that acetylation of p53 in vivo may contribute, at least in part, to its transcriptional activation functions.

The regulation of radiosensitivity by p53 and its acetylation.

Arginine Methylation of Hnrnp K Enhances P53 Transcriptional Activity.

Deciphering the acetylation code of p53 in transcription regulation and tumor suppression

Post-translational modifications:the molecular basis for p53 regulation

Functional Analysis of the Acetylation of Human P53 in DNA Damage Responses

Deacetylation of P53 Modulates Its Effect on Cell Growth and Apoptosis

Acetylation of P53 Augments Its Site-Specific DNA Binding Both in Vitro and in Vivo.

Regulation of Tip60‐dependent P53 Acetylation in Cell Fate Decision

Functional Investigations of p53 Acetylation Enabled by Heterobifunctional Molecules

Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression

An EZH2-mediated Epigenetic Mechanism Behind P53-Dependent Tissue Sensitivity to DNA Damage.

Acetylation Of P53 Inhibits Its Ubiquitination By Mdm2

Acetylation Is Indispensable for p53 Activation

Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage.

Dynamics of the p53 acetylation pathway.

Acetylation of P53 Protein at Lysine 120 Up-regulates Apaf-1 Protein and Sensitizes the Mitochondrial Apoptotic Pathway*

p53 modifications: exquisite decorations of the powerful guardian

Regulation of P53 Stability As a Therapeutic Strategy for Cancer.

p53 dynamics vary between tissues and are linked with radiation sensitivity

Targeting P53 for Novel Anticancer Therapy.

Acetylation Halts Missense Mutant P53 Aggregation and Rescues Tumor Suppression in Non-Small Cell Lung Cancers.